Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02084056
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.

Who this might be right for
Healthy
Boehringer Ingelheim 74
Early research (Phase 1)Study completedNCT01463228
What this trial is testing

Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Who this might be right for
Healthy
Janssen Research & Development, LLC 83
Not applicableUnknownNCT05636839
What this trial is testing

UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3

Who this might be right for
PsoriasisAtopic Dermatitis
National Taiwan University Hospital 20
Early research (Phase 1)Study completedNCT04006704
What this trial is testing

Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets

Who this might be right for
HIV-1
Janssen Pharmaceutica N.V., Belgium 25
Large-scale testing (Phase 3)Study completedNCT07043634
What this trial is testing

Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects

Who this might be right for
Bioavailability Heathy Volunteers
Sarfez Pharmaceuticals, Inc. 24
Early research (Phase 1)WithdrawnNCT06290622
What this trial is testing

PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaLymphoma, B-CellLymphoma, Follicular
University of Alabama at Birmingham
Large-scale testing (Phase 3)Study completedNCT01292460
What this trial is testing

Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

Who this might be right for
Ocular HypertensionOpen-angle Glaucoma
Santen Oy 600
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Testing effectiveness (Phase 2)Study completedNCT03642067
What this trial is testing

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Who this might be right for
Microsatellite Stable (MSS) Colorectal AdenocarcinomasColorectal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Post-approval studies (Phase 4)Ended earlyNCT02895958
What this trial is testing

The Dublin Zepatier Study

Who this might be right for
Hepatitis C
Mater Misericordiae University Hospital 3
Early research (Phase 1)Study completedNCT02720068
What this trial is testing

Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001)

Who this might be right for
Neoplasms
Merck Sharp & Dohme LLC 481
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567469
What this trial is testing

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

Who this might be right for
High-Grade Glioma (HGG)Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals 120
Post-approval studies (Phase 4)Study completedNCT01059422
What this trial is testing

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Central Institute of Epidemiology, Moscow, Russia 10
Early research (Phase 1)Ended earlyNCT03059303
What this trial is testing

Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

Who this might be right for
Healthy
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Study completedNCT03749642
What this trial is testing

Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy

Who this might be right for
Painful Diabetic Neuropathy
Aziende Chimiche Riunite Angelini Francesco S.p.A 240
Early research (Phase 1)Looking for participantsNCT07314346
What this trial is testing

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 32
Not applicableStudy completedNCT04835961
What this trial is testing

AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.

Who this might be right for
Asthma
Elpen Pharmaceutical Co. Inc. 1,037
Testing effectiveness (Phase 2)Study completedNCT06193408
What this trial is testing

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Who this might be right for
Cholera
Hunazine Biotech S.L. 150
Early research (Phase 1)UnknownNCT05737771
What this trial is testing

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

Who this might be right for
FDCDiabetes Mellitus, Type 2
Daewoong Pharmaceutical Co. LTD. 40
Early research (Phase 1)Study completedNCT01797926
What this trial is testing

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Who this might be right for
Hypertension
GlaxoSmithKline 102
Next Page